DIA 2015 Editor's Take - MedPoint Digital

 MedPoint Digital |  16 June 2015 |  Category: News 

Bill Cooney discusses how studies are becoming digital, how this impacts clinical research subjects, and how the industry needs to adapt.

In this interview, Bill Cooney discusses the need for the clinical research community to consider the digital patient in the larger context of consumer and healthcare markets, where advances are more rapid and profound. In coming years, clinical research will be challenged merely to keep pace with how mobile devices, apps and cloud technology transform consumer behavior. To avoid falling far behind the expectations of digital patients, drug developers need to immediately start using apps and mobile devices in trials. Cooney points out the, while some sponsors are conducting pilots seeking to transform the paradigm for clinical trials, other sponsors can use new digital formats in safer, more modest ways, and should start doing so immediately.

◀ Blog

Ready to reach and engage HCPs in new digital formats?

Contact Us

Ready to streamline and empower your clinical trials?

Contact Us